STAT+: Boom and bust: Whose biotech VC assets have grown and shrunk the most?
Money has gushed into the biotech industry over the last couple of years, as the pandemic brought the industry onto center stage. At the same time, tech investors have rushed into the arena.
Who has benefited the most?
